Parathyroid hormone and its related peptides in bone metabolism.


Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
10 2021
Historique:
received: 13 04 2021
revised: 29 06 2021
accepted: 30 06 2021
pubmed: 6 7 2021
medline: 16 11 2021
entrez: 5 7 2021
Statut: ppublish

Résumé

Parathyroid hormone (PTH) is an 84-amino-acid peptide hormone that is secreted by the parathyroid gland. It has different administration modes in bone tissue through which it promotes bone formation (intermittent administration) and bone resorption (continuous administration) and has great potential for application in sbone defect repair. PTH regulates bone metabolism by binding to PTH1R. PTH plays an osteogenic role by acting directly on mesenchymal stem cells, cells with an osteoblastic lineage, osteocytes, and T cells. It also participates as an osteoclast by indirectly acting on osteoclast precursor cells and osteoclasts and directly acting on T cells. In these cells, PTH activates the Wnt signaling, cAMP/PKA, cAMP/PKC, and RANKL/RANK/OPG pathways and other signaling pathways. Although PTH(1-34), also known as teriparatide, has been used clinically, it still has some disadvantages. Developing improved PTH-related peptides is a potential solution to teriparatide's shortcomings. The action mechanism of these PTH-related peptides is not exactly the same as that of PTH. Thus, the mechanisms of PTH and PTH-related peptides in bone metabolism were reviewed in this paper.

Identifiants

pubmed: 34224692
pii: S0006-2952(21)00282-3
doi: 10.1016/j.bcp.2021.114669
pii:
doi:

Substances chimiques

PTH1R protein, human 0
PTHLH protein, human 0
Parathyroid Hormone 0
Parathyroid Hormone-Related Protein 0
Receptor, Parathyroid Hormone, Type 1 0
Teriparatide 10T9CSU89I

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114669

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Tianhong Chen (T)

Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, China.

Yi Wang (Y)

Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, China.

Zhuowen Hao (Z)

Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, China.

Yingkun Hu (Y)

Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, China.

Jingfeng Li (J)

Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: jingfengli@whu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH